首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial
【2h】

A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial

机译:一项确定小儿患者败血性休克逆转是否更快的试验该患者被随机分配到早期目标导向的积液策略与常规护理(SQUEEZE):一项试验性随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCurrent pediatric septic shock resuscitation guidelines from the American College of Critical Care Medicine focus on the early and goal-directed administration of intravascular fluid followed by vasoactive medication infusions for persistent and fluid-refractory shock. However, accumulating adult and pediatric data suggest that excessive fluid administration is associated with worse patient outcomes and even increased risk of death. The optimal amount of intravascular fluid required in early pediatric septic shock resuscitation prior to the initiation of vasoactive support remains unanswered.
机译:背景技术目前美国重症医学学院的小儿败血性休克复苏指南着重于血管内液体的早期和目标导向给药,然后进行持续性和难治性休克的血管活性药物输注。但是,不断积累的成人和儿科数据表明,过量输液与患者预后差甚至死亡风险增加有关。在开始血管活性支持之前,早期的小儿败血性休克复苏所需的最佳血管内液量仍未得到解答。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号